| Reporter | TradeFlow | ProductCode | Product Description | Year | Partner | Trade Value 1000USD | Quantity | Quantity Unit |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | World | 846.66 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United Arab Emirates | 169.48 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Vietnam | 169.05 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | New Zealand | 102.93 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Kuwait | 92.05 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Lebanon | 34.44 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Iran, Islamic Rep. | 34.16 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Ghana | 27.41 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Egypt, Arab Rep. | 22.45 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Oman | 18.83 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Papua New Guinea | 18.48 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Colombia | 18.44 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Thailand | 16.65 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Israel | 15.90 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Fiji | 15.28 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Vanuatu | 12.21 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | East Timor | 10.89 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Djibouti | 9.97 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Mauritius | 7.84 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Tonga | 7.27 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Myanmar | 7.24 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Singapore | 5.50 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Italy | 5.42 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Solomon Islands | 5.35 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Kiribati | 4.59 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Samoa | 3.89 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | South Africa | 3.63 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | United States | 2.17 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Christmas Island | 1.90 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Philippines | 1.68 | | |
| Australia | Export | 300630 | Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | 2019 | Tuvalu | 1.55 | | |
